MedPath

Web-based self-management of insulin titration in patients with type 2 diabetes: The Di@log Study

Conditions
diabetes mellitus type 2 (DM type II)
Registration Number
NL-OMON27433
Lead Sponsor
VU Universtity Medical Center, EMGO institute
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
248
Inclusion Criteria

1. Patients with type 2 diabetes mellitus from general practices

2. Age between 35 and 75 years

Exclusion Criteria

1. Serious mental impairment

2. Serious endocrine disorders

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Difference between intervention and control groups in glycaemic control measured by glycated haemoglobin concentration (HbA1c-level)
Secondary Outcome Measures
NameTimeMethod
1. Treatment satisfaction <br /><br>2. Quality of life<br /><br>3. Self-efficacy<br /><br>4. Illness perceptions<br /><br>5. Patient-reported number of hypoglycaemias <br><br>6. Weight gain<br /><br>7. Total required insulin dose <br /><br>8. Time delay to reach stable insulin dose<br /><br>9. Changes in lipid spectrum<br /><br>10. (Oral) medication changes<br /><br>11. Frequency of contact with health care providers <br /><br>12. Frequency of log-ins on the site and use of different pages of the site
© Copyright 2025. All Rights Reserved by MedPath